116 related articles for article (PubMed ID: 20362622)
1. Attenuation of defined Brucella melitensis wboA mutants.
Nikolich MP; Warren RL; Lindler LE; Izadjoo MJ; Hoover DL
Vaccine; 2010 Oct; 28 Suppl 5():F12-6. PubMed ID: 20362622
[TBL] [Abstract][Full Text] [Related]
2. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
3. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
[TBL] [Abstract][Full Text] [Related]
5. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
6. Identification of smooth and rough forms in cultures of Brucella melitensis strains by flow cytometry.
Fernandez-Prada CM; Zelazowska EB; Bhattacharjee AK; Nikolich MP; Hoover DL
J Immunol Methods; 2006 Aug; 315(1-2):162-70. PubMed ID: 16965789
[TBL] [Abstract][Full Text] [Related]
7. In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.
Wang Z; Niu J; Wang S; Lv Y; Wu Q
Clin Vaccine Immunol; 2013 Feb; 20(2):174-80. PubMed ID: 23239800
[TBL] [Abstract][Full Text] [Related]
8. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
[TBL] [Abstract][Full Text] [Related]
9. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
10. A Brucella melitensis high temperature requirement A (htrA) deletion mutant demonstrates a stress response defective phenotype in vitro and transient attenuation in the BALB/c mouse model.
Phillips RW; Elzer PH; Roop RM II
Microb Pathog; 1995 Nov; 19(5):227-84. PubMed ID: 8778563
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.
Kahl-McDonagh MM; Ficht TA
Infect Immun; 2006 Jul; 74(7):4048-57. PubMed ID: 16790778
[TBL] [Abstract][Full Text] [Related]
12. Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.
Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Hadfield TL; Hoover DL
Infect Immun; 2004 Jul; 72(7):4031-9. PubMed ID: 15213148
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous expression of homologous and heterologous antigens in rough, attenuated Brucella melitensis.
Bandara AB; Poff-Reichow SA; Nikolich M; Hoover DL; Sriranganathan N; Schurig GG; Dobrean V; Boyle SM
Microbes Infect; 2009 Mar; 11(3):424-8. PubMed ID: 19397881
[TBL] [Abstract][Full Text] [Related]
14. Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.
Fernandez-Prada CM; Nikolich M; Vemulapalli R; Sriranganathan N; Boyle SM; Schurig GG; Hadfield TL; Hoover DL
Infect Immun; 2001 Jul; 69(7):4407-16. PubMed ID: 11401980
[TBL] [Abstract][Full Text] [Related]
15. An RpoH-like heat shock sigma factor is involved in stress response and virulence in Brucella melitensis 16M.
Delory M; Hallez R; Letesson JJ; De Bolle X
J Bacteriol; 2006 Nov; 188(21):7707-10. PubMed ID: 16936018
[TBL] [Abstract][Full Text] [Related]
16. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
[TBL] [Abstract][Full Text] [Related]
17. A multicopper oxidase contributes to the copper tolerance of Brucella melitensis 16M.
Wu T; Wang S; Wang Z; Peng X; Lu Y; Wu Q
FEMS Microbiol Lett; 2015 Jun; 362(12):fnv078. PubMed ID: 25956175
[TBL] [Abstract][Full Text] [Related]
18. Rough brucella strain RM57 is attenuated and confers protection against Brucella melitensis.
Feng Y; Peng X; Jiang H; Peng Y; Zhu L; Ding J
Microb Pathog; 2017 Jun; 107():270-275. PubMed ID: 28390976
[TBL] [Abstract][Full Text] [Related]
19. The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.
Commander NJ; Spencer SA; Wren BW; MacMillan AP
Vaccine; 2007 Jan; 25(1):43-54. PubMed ID: 17049676
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
Adone R; Francia M; Ciuchini F
Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
